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Introduction & Objectives: The introduction of robot-assisted laparoscopic radical prostatectomy (RALP) has opened a debate concerning prioritization of the economic resources used between RALP and retropubic radical prostatectomy (RRP). Information about the economic consequences and effects are needed in order to help the decision makers make better judgements about investments in operative equipment for RALP. Such information is lacking and to our knowledge no published cost-effectiveness study of RALP versus RRP is available. 

The purpose of our study was therefore to make a cost-effectiveness and cost-utility analysis of RALP versus RRP.

Material & Methods: In a retrospective cohort study a total of 231 men between the age 50-69 years and with clinical T1-T2 stage operated radical prostatectomy at the Department of Urology, Aarhus University Hospital, Skejby during January 1st 2004 until December 31st 2007, were included.

The patients were matched on the basis of age and The D’Amico Risk Classification of Prostate Cancer 1:2 for RALP and RRP; 77 and 154 respectively.

An economic evaluation was made to estimate the incremental cost-effectiveness ratio (ICER) per successful operation and quality adjusted life-years (QALY). A successful operation was defined as postoperative prostate-specific antigen < 0.2 ng/ml, urinary continence, and erectile function. QALYs were calculated from repeated measurements of the health related quality of life in patients using SF-36 and Braziers algorithm. Effects and costs were estimated during the first postoperative year. Further, costs for RALP were estimated assuming that 70 RALP were performed per year and including fixed costs for the da Vinci® robot with 110 robot operations yearly. A one-way sensitivity analysis was undertaken in order to investigate the impact on the study results.

Results 
The ICER per extra successful operation was €64,365 using RALP at one year postoperative. No QALY was gained one year after RALP. The sensitivity analysis did not change these results noticeable; however a larger number of surgeries per year improved the cost-effectiveness result for RALP. 

Conclusions
The new technology RALP is unsurprisingly more costly than the traditional RRP. However, RALP seems to be more effective at one year follow-up concerning successful operation. Regarding QALY, RALP was less effective than RRP. The assessment of cost-effectiveness is therefore not clear when comparing RALP with RRP but the high ICER seems to support the statement that RALP in the studied setting is mainly not cost-effective. RALP performed in high-volume centres would bring the judgement of cost-effectiveness closer to acceptance for introducing this new technology. Our results may contribute to an evidence based discussion of the dissemination of the robot-assisted technology and for better understanding of costs associated with radical prostatectomy. 
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